GENE ONLINE|News &
Opinion
Blog

Joy Lin

Without knowledge, there is no imagination. Without imagination, knowledge is meaningless

WRITTEN BY Joy Lin

Is the Race On for RNAi? A Chinese Pharma’s $450M Deal May Just Be the Start
2021-10-13
Pacira Acquires Flexion for $425 Million to Expand Non-Opioid Painkiller Portfolio
2021-10-12
BeiGene Gets Its First Regulatory Nod in Australia for Rare Lymphoma
2021-10-08
Takeda Hits the Brakes on Narcolepsy Drug Trials
2021-10-07
BioCina Acquires Pfizer Manufacturing Facility in Australia to Produce mRNA Vaccines
2021-10-06
Oxford Nanopore Soars on London Market Debut
2021-10-05
FDA Approves Kite’s CAR-T Therapy for Adult Leukemia
2021-10-04
Checkpoint Inhibitors as Part of Neoadjuvant Therapy in TNBC: Should We Use Them or Not?
2021-10-03
Wanting In on US Market, Cynata Taps Fujifilm to Advance Stem Cell Products
2021-10-01
AstraZeneca Acquires Caelum in $500m Deal to Strengthen Rare Diseases Division
2021-09-30
Syndax, Incyte Sign $602 Million Collab to Advance Monoclonal Antibody
2021-09-29
Takeda’s Allogeneic Stem Cell Therapy Becomes First of Its Kind to Be Approved in Japan
2021-09-28
Cue Health’s $200 Million Nasdaq IPO: Where Will the Ball Roll Next?
2021-09-27
Foxconn Subsidiary Invests $90.8 Million in Taiwanese CDMO, EirGenix
2021-09-24
New Study Supports Llama Nanobodies As Potential COVID-19 Treatment
2021-09-23
1 … 21 22 23 24 25
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top